Navigation Links


RNAi in Biological Technology

Sigma-Aldrich Introduces MISSION(R) esiRNA for Low Cost, High Specificity Pooled RNAi Screening

ST. LOUIS, April 28 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL ) today announced the global release of MISSION(R) esiRNA, a pool of gene-specific siRNA that provides a novel and powerful approach to RNAi screening in mammalian cells. Unlike traditional synthetic RNAi, esiRNA ( htt...

Senetek PLC Acquires Rights to Additional Anticancer RNAi Technology

NAPA, Calif., Dec. 15 /PRNewswire-FirstCall/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today announced an agreement with the Institute of Bioorganic Chemistry of the Polish Academy of Sci...

Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics

PALO ALTO, Calif., Dec. 2 /PRNewswire/ -- Intradigm Corporation, a leading developer of targeted, systemic RNA interference (RNAi) therapeutics, today announced the issuance of United States patent 7,459,547, entitled "Methods and Compositions for Controlling Efficacy of RNA Silencing." The issue...

Sigma-Aldrich Introduces MISSION(R) In VIVO QUALITY and iScale Oligos(TM) siRNA, a Superior Quality siRNA Designed for RNAi Research in Animal Models

ST. LOUIS, Nov. 20 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL ) announced today the global release of MISSION(R) In VIVO QUALITY and iScale Oligos(TM) siRNA. MISSION(R) In VIVO QUALITY and iScale Oligos(TM) siRNA are expected to allow researchers to successfully take the next step in ...

Cellectricon Receives Milestone Order for Cellaxess(R)HT, the World's First High Throughput RNAi Screening System

GOTHENBURG, Sweden, November 12 /PRNewswire/ -- Cellectricon, a leading provider of advanced screening solutions for drug discovery, has today received its most significant and largest single order to date. The order includes three Cellaxess(R)HT systems and the customer is a leading US biotec...

Sigma-Aldrich Welcomes Memorial Sloan-Kettering Cancer Center to the RNAi Partnership Program

Researchers gain access to Sigma-Aldrich's leading MISSION(TM) shRNA libraries ST. LOUIS, Oct. 15 /PRNewswire/ -- Sigma-Aldrich (Nasdaq: SIAL ), a leading life science company and member of The RNAi Consortium (TRC), proudly welcomes the Memorial Sloan-Ketterin...

Quark Pharmaceuticals Announces Poster Presentations at RNAi Europe 2008

FREMONT, Calif., Sept. 17 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced the presentation of posters at the 5th Annual RNAi Europe, taking place September 16-18...

Silence Therapeutics Receives Allowance from United States Patent and Trademark Office for its Core RNAi Patent

U.S. AtuRNAi Patent Allowance Builds on European Equivalent Granted in 2007, Expanding Commercial Protection LONDON, July 31 /PRNewswire/ -- Silence Therapeutics plc (AIM: SLN), a leading European RNAi focused biotechnology company, today announced that the United States Paten...

Sigma-Aldrich Joins Phase 2 of The RNAi Consortium to Validate shRNA Libraries

Sigma-Aldrich to Provide Full Functional Validation Data for Its MISSION(R) shRNA Collection ST. LOUIS, May 7 /PRNewswire-FirstCall/ -- Sigma-Aldrich(TM) (Nasdaq: SIAL) and the second phase of The RNAi Consortium (TRC2) have commenced functional validation of the Conso...

febit to Introduce Geniom RT Analyzer(R) to U.S. Market at RNAi World Congress

RNA, microRNA Researchers Comprise One of the Main User Groups of febit's Simplified and Automated Microarray Technology MEDFORD, Mass., and HEIDELBERG, Germany, April 22 /PRNewswire/ -- febit holding gmbh today announced it will introduce the Geniom RT Analyzer(R) to the U.S. marke...

Open Biosystems' Open Access RNAi Program Adopted by University of Copenhagen and University of Queensland

Unique program continues to advance collaborative research worldwide HUNTSVILLE, Ala., April 7, 2008 /PRNewswire/ -- Open Biosystems, Inc., announced today that leading research institutions, the Institute for Molecular Bioscience and Diamantina Institute at the University of Queensland, and...

Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement to Develop and Commercialize RNAi Hepatitis C Drug

TOKYO and SAN JOSE, Calif., March 12 /PRNewswire/ -- Oncolys BioPharma, Inc. (Tokyo, Japan) and Tacere Therapeutics, Inc. (San Jose, CA, USA) announced today that they have entered into a strategic alliance and license agreement to develop and commercialize throughout Asia, Tacere's RNA interf...

Sirnaomics and GRL Establish Partnership for the Development of Two Multi-Targeted RNAi Therapeutics Products

ROCKVILLE, Md., March 12 /PRNewswire/ -- General Research Laboratory, Inc. (GRL) and Sirnaomics, Inc. announced today that the companies are advancing their partnership initiated in July 2007 for development of two RNA interference (RNAi) therapeutic products, following the successful identifi...

Altogen Biosystems Launches Custom Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services

LAS VEGAS, March 11 /PRNewswire/ -- Altogen Biosystems ( http://www.altogen.com ) announced launch of new contract research services. Located in Las Vegas, NV, Altogen Custom Services focus on providing specialized biotechnology and pharmaceutical services, including RNA Interference (RNAi) se...

Open Biosystems' Open Access RNAi Program Adopted by Harvard Medical School and University of North Carolina

Genome scale RNAi analysis affordable and accessible to all researchers HUNTSVILLE, Ala., March 11 /PRNewswire/ -- Open Biosystems, Inc. announced today that Harvard Medical School and the University of North Carolina have joined the Open Access(TM) RNAi Program. Each University purchased acce...

Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect

Mike Byrom, Vince Pallotta, David Brown*, and Lance Ford* Ambion, Inc. 2130 Woodward Street Austin, TX 78744-1832 * Corresponding authors dbrown@ambion.com ,

Cequent Names F. Stephen Laroux, Ph.D., Director, Immunology and Inflammatory Diseases

...ng drug candidates using Cequent's proprietary tk rnai delivery platform against a series of targets thou... drug candidate CEQ508, an orally administered tk rnai therapeutic targeting the primary oncogene (beta-c...acy. This is a testament to the promise of our tk rnai technology -- but also to Stephen's skills and ten...

Clontech Laboratories, Inc. Releases the Xfect(TM) and Xfect(TM) Stem Transfection Reagents

...fication tools. These and other products support applications including gene discovery, regulation, and function; protein expression and purification; rnai and stem cell studies; and plant and food research. For more information visit www.clontech.com . About Takara Bio Inc. Takara Bio Inc. i...

GeneCards(R) Version 3.0 Beta Released

...drugs & compounds and direct links to valuable research reagents and tools such as antibodies, recombinant proteins, clones, expression assays and rnai reagents. GeneCards was developed over the last 12 years by a world-leading bioinformatics team at the Weizmann Institute of Science in Israel, direct...

Quark Pharmaceuticals Presented At ARVO Data Showing That PF-04523655 Enters Retinal Cells And Elicits Its Pharmacologic Effect Via Target Gene Knock-Down Without Activating TLR3

...m that spans therapeutic target identification to drug development. Quark's rnai technology includes novel siRNA structures and chemistry providing Quark wi...rnally. The Company expects to utilize the structures to develop additional rnai drug candidates. Quark is headquartered in Fremont, California and ope...

Divergence Receives $1.2 Million in Grants, Including NSF Grant to Fund Continuing Nematode Research in Corn

...ulting in a larger, healthier root system for a plant. The Phase II grant will allow Divergence to expand greenhouse testing in crops including corn. rnai is a fundamental mechanism of gene regulation triggered by double-stranded RNA. Divergence was an early industrial adopter of RNAi, working with the ...

Roche Madison Moves to New Facility

...c acid based technologies, including a proprietary rnai (Ribonucleic Acid interference) delivery platform. rnai - a natural mechanism that the body uses to 'silen...andscape and to finding innovative ways of getting rnai therapeutics into specific disease targets to bene...

Quark Pharmaceuticals to Present at American Society for Pharmacology and Experimental Therapeutics Annual Meeting

... of oligonucleotide therapeutics. Other leaders in rnai will also present during the session including: Pa...Special issues in the discovery and development of rnai therapeutics); Christina Gamba-Vitalo, Senior Dire...ion in this session alongside respected leaders in rnai development. The invitation reinforces that the dr...

Xennex Inc. Providing Satoris Inc. with Latest GeneCards(R) Tools for Characterization of Protein Biomarkers Associated With Neurological Conditions

...s & compounds and direct links to cutting-edge research reagents and tools such as antibodies, recombinant proteins, clones, expression assays and rnai reagents. GeneCards was developed over the last 12 years by a world-leading bioinformatics team at the Weizmann Institute of Science in Israel. ...

Frost & Sullivan Recognizes Life Technologies for Excellence in the Life Science Research Tools Industry

...assays market, the research ELISA market, the high content screening market, the liquid chromatography market, the protein electrophoresis market, the rnai market, and the proteomics array market." Life Technologies offers approximately 50,000 products and lays claim to an incredibly strong technolog...

Frost & Sullivan Recognizes Nanopoint for its Pioneering Cell Imaging Solution, the cellTRAY(R) Imaging System CT-2000

...eriments could be performed, stem cell differentiation can be observed, and rnai knockdowns could be performed. "The cellTRAY(R) Imaging System can be ...m cell research, toxicology research, Nano particle, C dot, Q dot research, rnai research and IVF research," notes Priya. "Further, the company has four iss...

Intradigm Receives Notice of Allowance for Key RNA Interference (RNAi) Patent Covering Potent siRNA Sequence

...any Patents in Each of the Three Critical Areas of rnai Therapeutic Development PALO ALTO, Calif., Ma...(IP) covering each of the three critical areas for rnai therapeutic development: target sequences, deliver...Intradigm in a uniquely strong position within the rnai therapeutic industry, especially among other priva...

Sigma-Aldrich Streamlines Access to Advanced Stem Cell Research Portfolio and Opens Stem Cell Biology Community Through New Web Portal

...ortal's expanding line of cutting-edge technologies for stem cell research includes the industry's most highly-validated shRNA library, the MISSION(R) rnai portfolio, which enables gene silencing across a wide range of cellular targets. The site also features the CompoZrTM zinc finger nuclease (ZFN) reage...

Sigma-Aldrich Introduces MISSION(R) LentiPlex(TM) Pooled shRNA Libraries to Enable Rapid Whole Genome Screening in Primary Cells, Stem Cells or Tumor Cells

...m/lentiplex ). Using the shRNA collections of The rnai Consortium (TRC), the MISSION LentiPlex Pooled shRNA Libraries enable rapid, genome-wide rnai screening at the bench-top level in a convenient a... format enables researchers to perform genome-wide rnai screens on various cell types, rapidly and efficie...

Cequent Names Ted Hibben Chief Business Officer

...even more important as we continue to move our tk rnai technology from the laboratory into clinical devel...e to license our technology to deliver therapeutic rnai for novel metabolic, oncology, or other targets." ...genic bacteria as an engine to produce and deliver rnai directly into cells. It is based on ground-breakin...
Other TagsPatelGrasp
(Date:11/24/2009)... class of ring-shaped protein motors has been unco...tional Laboratory (Berkeley Lab) using a state-of-...vanced Light Source (ALS). These protein motors pl...n, and are vital to the survival of all biological...human papillomavirus, which has been linked to cer...
(Date:11/24/2009)...2009) -- The Wildlife Conservation Society (WCS) a...maining population of Siberian tigers has likely d...aching and habitat loss. , WCS says ...hat needs to be done to protect remaining populati...he report was released by the Siberian Tiger Monit...
(Date:11/24/2009)... of debate. A high-profile study a few years ago s...carbon from trees and leaves, evidence for a very ...systems. , But new research from the University ... Algae provide a much richer diet for fish and oth...his week in the Proceedings of the National Acade...
Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Report shows dramatic decline in Siberian tigers 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Veran Medical Technologies Announces Intellectual Property Agreement With Medtronic 47443 1Veran Medical Technologies Announces Intellectual Property Agreement With Medtronic 47443 2Unprecedented Merger Occurs in Retained Physician Search Industry 47441 1Unprecedented Merger Occurs in Retained Physician Search Industry 47441 2Unprecedented Merger Occurs in Retained Physician Search Industry 47441 3PROSTVAC 28TM 29 Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late Stage Prostate Can 12379 1PROSTVAC 28TM 29 Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late Stage Prostate Can 12379 2PROSTVAC 28TM 29 Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late Stage Prostate Can 12379 3
(Date:11/26/2009)...ring drug tetrathiomolybdate (TM) has been shown i...on disease, a disease caused by an overload of cop...known. Very little, however, is known about how th...dy led by Northwestern University researchers now ...onal structure of TM bound to copper-loaded metall...
(Date:11/26/2009)...ill when on an emotional rollercoaster, study find... -- Call it the fear factor meets the jubilant spo... -- especially those who root for the winning team...ely contested match and victory was in doubt, prod...w on that this Thanksgiving weekend as you,re glue...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again Center, ... , is one of a growing number of physicians who ar...ites to connect with individuals who are intereste...d obesity. Dr. Kim is utilizing Facebook to share ...practice with the community. , ...
(Date:11/26/2009)... Benton Communications announces a highly effe...r retailers struggling to make an economic recover... 2009 -- Flu fears is the type of challenge that c...om, according to Dr. David Benton, business growth...growth system – The Rfactor Intensive . &...
(Date:11/25/2009)...ov.25/PRNewswire-USNewswire/--Whenmostpeoplehearth...orcanalsogivepatientsthehelptheyneed.TMJstandsfort...dible)contacts/connectswithyourskull(temporalbone)...unctionarepainwithchewing,clickingorpoppingoftheja...nincluding:headaches,fatigue,sleepdisturbances,irr...
Breaking Medicine News(10 mins):Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Pharmacist Injects Cure for Ailing Businesses 2
Other Contentsfecalfecalfecalfecalfebrilefebrilefebrilecondomscondomscondomsfemalefemalefemalefemalefemalefemalefemalefemaledevelopmentdevelopmentdevelopmentdevelopmentdevelopmentdevelopmentdevelopmentdevelopmentdevelopmentdevelopmentfemoralfemoralfemoralfertilityfertilityfertilityfertilityfertilityfertilityfertilityfertility